Health and Human Services News and Research

RSS

Ortho-McNeil Pharmaceutical pleads guilty for promoting epilepsy drug Topamax for psychiatric use

Ortho-McNeil Pharmaceutical LLC, a subsidiary of Johnson & Johnson, pled guilty today in U.S. District Court in Boston to one count of misdemeanor violation of the Food, Drug & Cosmetic Act for illegally promoting its epilepsy drug Topamax for uses that were not approved by the FDA. The company was also sentenced at today's hearing.

24 May 2010

New national standards issued for newborn screening

New national standards issued today will assist states to align their newborn screening programs with "the most up-to-date research, technology, laboratory and public health standards and practices."

24 May 2010

Common myths about tanning and sun protection

Half the battle in knowing how to properly protect oneself from skin cancer is being able to separate fact from fiction. Unfortunately, some myths about tanning and sun protection are deep rooted and could mislead people into thinking that tanning is safe - when, in reality, nothing could be further from the truth.

24 May 2010

KHN column: The prevention dilemma

In this Kaiser Health News column, Partnership for Prevention President and CEO Robert Gould writes: "If given the choice to spread prevention money around or to concentrate it to make a profound, historic and measurable impact, what would you do?

24 May 2010

Eli Lilly to honor individuals with Welcome Back Award for improving lives of others

Despite years of debilitating depression, multiple psychiatric hospitalizations and episodes of homelessness, Joseph Rogers refused to let mental illness and an unlucky adolescence blot out his potential imprint on the world. Despite once being branded unemployable, Joseph relishes his role as advocate, embracing the challenges of being a change agent in mental health legislation, and pioneering the peer-run services movement.

21 May 2010

First Edition: May 21, 2010

In today's headlines, legislation containing a Medicare pay 'fix' and an extension of the COBRA subsidy is moving toward House consideration.

21 May 2010

SAMHSA study reveals differences in rates of substance use among various Asian-American adults

A new national study by the Substance Abuse and Mental Health Services Administration (SAMHSA) shows there are significant differences in rates of substance use among adults in various Asian-American populations. For example, the past month binge drinking rate among Korean-American adults is three times higher than among Chinese-American adults (25.9 percent versus 8.4 percent). Similarly the level of past month illicit drug use among Japanese-American adults is nearly three times higher than the level among Asian Indian-American adults.

21 May 2010

Medicare to evaluate how beneficiaries used personal health records

The Department of Health and Human Services is preparing to evaluate a 17-month-old pilot program that has tested whether beneficiaries use personal health records (PHR) in Utah and Arizona, Modern Healthcare reports.

21 May 2010

GSK, EMBL-EBI, NLM and CDD collaborate to apply principles of open source to drug discovery for malaria

GlaxoSmithKline (GSK) had teamed up with leading public-domain data providers European Bioinformatics Institute (EMBL-EBI), the U.S. National Library of Medicine (NLM) and the U.S.-based informatics service provider Collaborative Drug Discovery (CDD) to make freely available key scientific information on more than 13,500 compounds that could ultimately lead to new treatments for malaria.

20 May 2010

ABBOTT PRISM Chagas test receives FDA approval

Abbott received Biologic License Application (BLA) approval from the United States Food and Drug Administration (FDA) for the ABBOTT PRISM Chagas test. The test is a fully automated blood screening assay that can detect antibodies to Trypansoma cruzi (T. cruzi), a parasite found only in the Americas and most commonly acquired through contact with the blood-sucking triatomine or "kissing bug."

19 May 2010

HHS sends letter to Committee on Education and Labor over improper practices by Head Start grantees

U.S. Department of Health and Human Services (HHS) Secretary Kathleen Sebelius sent a letter to Chairman George Miller and the Committee on Education and Labor regarding the Government Accountability Office (GAO) investigation into improper practices by Head Start grantees. The investigation is the subject of the Committee's upcoming hearing. Secretary Sebelius' letter outlines HHS's plans and steadfast commitment to upholding the integrity of this critical program.

19 May 2010

Research findings help explain diverse genetic susceptibility for alcohol use disorders

A genetic variant of a receptor in the brain's reward circuitry plays an important role in determining whether the neurotransmitter dopamine is released in the brain following alcohol intake, according to a study led by researchers at the National Institute on Alcohol Abuse and Alcoholism, part of the National Institutes of Health. Dopamine is involved in transmitting the euphoria and other positive subjective effects produced by alcohol.

19 May 2010

Two common operations for SUI help women achieve similar levels of dryness: Study

Two common operations for stress urinary incontinence help women achieve similar levels of dryness, according to a team of urologists and urogynecologists who compared the treatments in a large U.S. trial supported by the National Institutes of Health. The study is being released online May 17, 2010, by the New England Journal of Medicine to coincide with a presentation at the annual meeting of the American College of Obstetrics and Gynecology. Results will appear in the June 3 print edition.

19 May 2010

GHESKIO awarded prestigious 2010 Gates Award for Global Health

GHESKIO, an institution in Haiti founded nearly three decades ago to fight a mysterious killer disease later identified as AIDS, has been awarded the prestigious 2010 Gates Award for Global Health for its years of groundbreaking clinical service, research and training to effectively treat and prevent the spread of the HIV/AIDS and other related illnesses.

19 May 2010

To sell plan, White House officials focus on four key aspects of health reform

White House officials eager to sell the most popular aspects of the health reform law are focusing on four areas to gain votes and popularity for key lawmakers ahead of November's midterm elections.

19 May 2010

WPI, Cerus announce positive results from study of INTERCEPT Blood System to inactivate XMRV

The Whittemore Peterson Institute for Neuro-Immune Disease (WPI) and Cerus Corporation announced positive results from a study demonstrating the efficacy of the INTERCEPT Blood System to inactivate XMRV, a human retrovirus, in donated platelet components.

18 May 2010

ICF International awarded multi-year contract to support community action in reducing chronic disease

ICF International, a leading provider of consulting services and technology solutions to government and commercial clients, has been awarded a new $11.6 million multi-year contract by the U.S. Department of Health and Human Services, Centers for Disease Control and Prevention, to develop a resource center for broad-scale community action to reduce chronic disease.

18 May 2010

Insurance groups seek to limit health law damage with medical-loss ratio definitions

Insurance groups are wrangling with regulators on defining a few key terms that will significantly alter how they do business under the new health reform law.

18 May 2010

Emergent BioSolutions' anthrax monoclonal antibody IND for Phase I study clears FDA review

Emergent BioSolutions Inc. announced today that its Investigational New Drug (IND) application, to commence a Phase I clinical trial for its anthrax monoclonal antibody therapeutic, has cleared U.S. Food and Drug Administration (FDA) review. The Phase I study will evaluate the safety and pharmacokinetics of the company's fully human monoclonal antibody being developed as a parenteral post-exposure therapy for individuals who have symptoms of anthrax disease. In pre-clinical therapeutic studies, Emergent's monoclonal antibody was found to be effective.

17 May 2010

Early CPAP as effective for preemies as ventilator, with fewer complications: Study

Two findings from an NIH research network study provide new information on how much oxygen very preterm infants should receive starting on the first day of life and the most effective means to deliver it to them.

17 May 2010

Health and Human Services News and Research

Ortho-McNeil Pharmaceutical pleads guilty for promoting epilepsy drug Topamax for psychiatric use

New national standards issued for newborn screening

Common myths about tanning and sun protection

KHN column: The prevention dilemma

Eli Lilly to honor individuals with Welcome Back Award for improving lives of others

First Edition: May 21, 2010

SAMHSA study reveals differences in rates of substance use among various Asian-American adults

Medicare to evaluate how beneficiaries used personal health records

GSK, EMBL-EBI, NLM and CDD collaborate to apply principles of open source to drug discovery for malaria

ABBOTT PRISM Chagas test receives FDA approval

HHS sends letter to Committee on Education and Labor over improper practices by Head Start grantees

Research findings help explain diverse genetic susceptibility for alcohol use disorders

Two common operations for SUI help women achieve similar levels of dryness: Study

GHESKIO awarded prestigious 2010 Gates Award for Global Health

To sell plan, White House officials focus on four key aspects of health reform

WPI, Cerus announce positive results from study of INTERCEPT Blood System to inactivate XMRV

ICF International awarded multi-year contract to support community action in reducing chronic disease

Insurance groups seek to limit health law damage with medical-loss ratio definitions

Emergent BioSolutions' anthrax monoclonal antibody IND for Phase I study clears FDA review

Early CPAP as effective for preemies as ventilator, with fewer complications: Study

Revolutionizing Life Science: An Interview with SCIEX on ASMS, the SCIEX 7500+ System, and AI-Driven Quantitation

From Discovery Biology to ELRIG Chair

Breathing New Life into Diagnostics: Plasmion's SICRIT Technology

Latest News